Ishitobi M - Search Results

1

High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer.

Miyoshi Y, Ando A, Hasegawa S, Ishitobi M, Taguchi T, Tamaki Y, Noguchi S. Miyoshi Y, et al. Among authors: ishitobi m. Clin Cancer Res. 2003 Jun;9(6):2288-93. Clin Cancer Res. 2003. PMID: 12796397

2

ASO Author Reflections: Is Nipple-Areolar Recurrence After Nipple-Sparing Mastectomy Simply a "Cosmetic Failure"?

Ishitobi M, Shien T. Ishitobi M, et al. Ann Surg Oncol. 2023 Mar;30(3):1687-1688. doi: 10.1245/s10434-022-12773-w. Epub 2022 Nov 15. Ann Surg Oncol. 2023. PMID: 36380252 No abstract available.

3

Mutational analysis of the class I beta-tubulin gene in human breast cancer.

Hasegawa S, Miyoshi Y, Egawa C, Ishitobi M, Tamaki Y, Monden M, Noguchi S. Hasegawa S, et al. Among authors: ishitobi m. Int J Cancer. 2002 Sep 1;101(1):46-51. doi: 10.1002/ijc.10575. Int J Cancer. 2002. PMID: 12209587

4

Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.

Ishitobi M, Miyoshi Y, Ando A, Hasegawa S, Egawa C, Tamaki Y, Monden M, Noguchi S. Ishitobi M, et al. Clin Cancer Res. 2003 Apr;9(4):1376-80. Clin Cancer Res. 2003. PMID: 12684407

5

Prediction of response to docetaxel by quantitative analysis of class I and III beta-tubulin isotype mRNA expression in human breast cancers.

Hasegawa S, Miyoshi Y, Egawa C, Ishitobi M, Taguchi T, Tamaki Y, Monden M, Noguchi S. Hasegawa S, et al. Among authors: ishitobi m. Clin Cancer Res. 2003 Aug 1;9(8):2992-7. Clin Cancer Res. 2003. PMID: 12912947

6

Mutational analysis of BARD1 in familial breast cancer patients in Japan.

Ishitobi M, Miyoshi Y, Hasegawa S, Egawa C, Tamaki Y, Monden M, Noguchi S. Ishitobi M, et al. Cancer Lett. 2003 Oct 8;200(1):1-7. doi: 10.1016/s0304-3835(03)00387-2. Cancer Lett. 2003. PMID: 14550946

7

Bilateral breast metastases of medullary thyroid cancer.

Ishitobi M, Tamaki Y, Yamamura J, Miyoshi Y, Monden M, Noguchi S. Ishitobi M, et al. Breast J. 2004 Mar-Apr;10(2):162. doi: 10.1111/j.1075-122x.2004.21295.x. Breast J. 2004. PMID: 15009049 No abstract available.

8

Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction.

Taniguchi K, Takano T, Miyauchi A, Koizumi K, Ito Y, Takamura Y, Ishitobi M, Miyoshi Y, Taguchi T, Tamaki Y, Kato K, Noguchi S. Taniguchi K, et al. Among authors: ishitobi m. Oncology. 2005;69(5):428-35. doi: 10.1159/000089998. Epub 2005 Nov 25. Oncology. 2005. PMID: 16319515

9

Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.

Motomura K, Ishitobi M, Komoike Y, Koyama H, Nagase H, Inaji H, Noguchi S. Motomura K, et al. Among authors: ishitobi m. Oncology. 2010;79(1-2):55-61. doi: 10.1159/000319540. Epub 2010 Nov 11. Oncology. 2010. PMID: 21071990

10

Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.

Ishitobi M, Ohsumi S, Inaji H, Ohno S, Shigematsu H, Akiyama F, Iwase T, Akashi-Tanaka S, Sato N, Takahashi K, Oura S. Ishitobi M, et al. Cancer. 2012 Sep 15;118(18):4385-93. doi: 10.1002/cncr.27377. Epub 2012 Jan 17. Cancer. 2012. PMID: 22252882 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters